Current News · Sourced report
Eugia US LLC (f/k/a Auro Medics Pharma LLC) Issues Voluntary Nationwide Recall of Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (Single Dose Vial) Due to Presence of Particulate Matter
FOR IMMEDIATE RELEASE -November 06,2026 - East Windsor, New Jersey, Eugia US LLC (f/k/a Auro Medics Pharma LLC) is voluntarily recalling lot number 3VM26026A of Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL
News Desk · Nov 9, 2026 · U.S. Food and Drug Administration
This item is a public release from the U.S. Food and Drug Administration. The source date is Nov 9, 2026. The next paragraph is the agency's own short text. Morning Column did not rewrite it.
FOR IMMEDIATE RELEASE -November 06,2026 - East Windsor, New Jersey, Eugia US LLC (f/k/a Auro Medics Pharma LLC) is voluntarily recalling lot number 3VM26026A of Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (Single Dose Vial) to the hospital/healthcare facility/user level due to the pre
The full release is on the source page. This page is not personal medical advice.
This page is general information from the sources below. It is not personal medical advice, a diagnosis, or a treatment plan. Talk with a qualified clinician about your own health. Read the disclaimer.
References
See a factual error? Write to contact@morningcolumn.com. The corrections log is public.